Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF (PANTHER-IPF)
This study is ongoing, but not recruiting participants.
Study NCT00650091   Information provided by Duke University

First Received on March 28, 2008.   Last Updated on March 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Lung Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
N-acetylcysteine (NAC)
Placebo
Additional drug interventions recognized in this trial
Acetylcysteine
Azathioprine
N-monoacetylcystine
Prednisone
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Inflammatory Agents
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antirheumatic Agents
Antiviral Agents
Expectorants
Free Radical Scavengers
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Duke University
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services